| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyloid beta-Peptides | 29 | 2021 | 251 | 6.310 |
Why?
|
| Amyloid | 14 | 2016 | 104 | 2.720 |
Why?
|
| Peptide Fragments | 21 | 2021 | 480 | 2.640 |
Why?
|
| Peptides | 20 | 2015 | 671 | 2.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2021 | 271 | 1.670 |
Why?
|
| Protein Aggregates | 5 | 2021 | 28 | 1.230 |
Why?
|
| Amino Acid Sequence | 31 | 2019 | 2008 | 0.940 |
Why?
|
| Microscopy, Atomic Force | 3 | 2021 | 54 | 0.800 |
Why?
|
| Alzheimer Disease | 9 | 2021 | 649 | 0.790 |
Why?
|
| Protein Structure, Secondary | 20 | 2015 | 341 | 0.740 |
Why?
|
| Amino Acids | 10 | 2006 | 247 | 0.720 |
Why?
|
| Models, Molecular | 20 | 2016 | 1396 | 0.700 |
Why?
|
| Molecular Sequence Data | 27 | 2015 | 2897 | 0.660 |
Why?
|
| Protein Conformation | 20 | 2021 | 931 | 0.610 |
Why?
|
| Membrane Lipids | 2 | 2019 | 41 | 0.600 |
Why?
|
| Disulfides | 1 | 2019 | 66 | 0.600 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 9 | 2021 | 65 | 0.590 |
Why?
|
| Biochemistry | 1 | 2019 | 29 | 0.580 |
Why?
|
| Protein Multimerization | 2 | 2011 | 195 | 0.580 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 5 | 2019 | 105 | 0.570 |
Why?
|
| Metals | 1 | 2019 | 105 | 0.570 |
Why?
|
| Nanoparticles | 1 | 2021 | 218 | 0.570 |
Why?
|
| Circular Dichroism | 14 | 2016 | 118 | 0.560 |
Why?
|
| Brain | 8 | 2021 | 2439 | 0.550 |
Why?
|
| Protein Folding | 4 | 2019 | 291 | 0.530 |
Why?
|
| Apolipoproteins E | 6 | 2001 | 139 | 0.530 |
Why?
|
| Thiazoles | 5 | 2011 | 127 | 0.490 |
Why?
|
| Meninges | 1 | 2016 | 14 | 0.470 |
Why?
|
| Nerve Tissue Proteins | 4 | 2014 | 526 | 0.460 |
Why?
|
| Isotope Labeling | 1 | 2016 | 54 | 0.460 |
Why?
|
| Protein Binding | 18 | 2014 | 1561 | 0.420 |
Why?
|
| Protein Denaturation | 3 | 2016 | 110 | 0.380 |
Why?
|
| Peptides, Cyclic | 2 | 2009 | 43 | 0.340 |
Why?
|
| Drug Design | 2 | 2009 | 135 | 0.330 |
Why?
|
| Water | 2 | 2021 | 309 | 0.330 |
Why?
|
| Mutant Proteins | 1 | 2011 | 99 | 0.320 |
Why?
|
| Lipoproteins | 3 | 2008 | 136 | 0.310 |
Why?
|
| Caprylates | 2 | 2007 | 11 | 0.310 |
Why?
|
| Recombinant Proteins | 5 | 2014 | 994 | 0.310 |
Why?
|
| Chaperonin Containing TCP-1 | 1 | 2010 | 1 | 0.310 |
Why?
|
| Antigens, Neoplasm | 6 | 2019 | 365 | 0.310 |
Why?
|
| Polyamines | 1 | 2009 | 38 | 0.290 |
Why?
|
| Kinetics | 11 | 2014 | 1477 | 0.290 |
Why?
|
| Mutation, Missense | 3 | 2009 | 309 | 0.280 |
Why?
|
| Chromatography, Gel | 7 | 2011 | 96 | 0.280 |
Why?
|
| Nuclear Proteins | 2 | 2010 | 755 | 0.280 |
Why?
|
| Humans | 53 | 2021 | 98370 | 0.270 |
Why?
|
| Apolipoprotein A-I | 4 | 2015 | 72 | 0.270 |
Why?
|
| Phenylalanine | 2 | 2009 | 31 | 0.260 |
Why?
|
| Animals | 46 | 2022 | 28981 | 0.260 |
Why?
|
| Benzothiazoles | 5 | 2011 | 19 | 0.260 |
Why?
|
| Binding Sites | 8 | 2019 | 1160 | 0.260 |
Why?
|
| X-Ray Diffraction | 5 | 2014 | 131 | 0.260 |
Why?
|
| Chromatography, High Pressure Liquid | 7 | 2019 | 307 | 0.250 |
Why?
|
| Mutation | 5 | 2016 | 4428 | 0.250 |
Why?
|
| Lipoprotein(a) | 2 | 1997 | 33 | 0.250 |
Why?
|
| Protein Structure, Tertiary | 7 | 2014 | 733 | 0.230 |
Why?
|
| Spectrometry, Fluorescence | 4 | 2016 | 83 | 0.230 |
Why?
|
| Protein Structure, Quaternary | 1 | 2006 | 105 | 0.230 |
Why?
|
| Homeostasis | 2 | 2019 | 474 | 0.230 |
Why?
|
| Microscopy, Electron | 7 | 2009 | 435 | 0.230 |
Why?
|
| Lactams | 3 | 2005 | 14 | 0.230 |
Why?
|
| Ligands | 5 | 2016 | 491 | 0.220 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 403 | 0.210 |
Why?
|
| Mice | 25 | 2022 | 12735 | 0.210 |
Why?
|
| Antigens, CD1 | 2 | 2016 | 37 | 0.200 |
Why?
|
| Glycoproteins | 3 | 2016 | 222 | 0.200 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2014 | 149 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2016 | 119 | 0.190 |
Why?
|
| Conserved Sequence | 3 | 2012 | 209 | 0.180 |
Why?
|
| Proteins | 5 | 2021 | 804 | 0.180 |
Why?
|
| Solubility | 2 | 2019 | 187 | 0.180 |
Why?
|
| Methylation | 4 | 2010 | 294 | 0.180 |
Why?
|
| Serine | 1 | 2022 | 106 | 0.180 |
Why?
|
| Protein Domains | 2 | 2019 | 170 | 0.170 |
Why?
|
| Antigen Presentation | 4 | 2016 | 234 | 0.170 |
Why?
|
| Ultracentrifugation | 4 | 2003 | 34 | 0.170 |
Why?
|
| Temperature | 2 | 2016 | 442 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2016 | 489 | 0.170 |
Why?
|
| Phosphoproteins | 1 | 2022 | 264 | 0.170 |
Why?
|
| Zinc | 1 | 2001 | 99 | 0.170 |
Why?
|
| Point Mutation | 6 | 2015 | 237 | 0.170 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2021 | 17 | 0.170 |
Why?
|
| Receptors, LDL | 2 | 1998 | 54 | 0.160 |
Why?
|
| Lipoproteins, LDL | 2 | 1999 | 87 | 0.160 |
Why?
|
| Dicarboxylic Acids | 2 | 1991 | 24 | 0.160 |
Why?
|
| Microscopy, Electron, Transmission | 3 | 2009 | 137 | 0.160 |
Why?
|
| Glycine | 2 | 2016 | 96 | 0.150 |
Why?
|
| Huntingtin Protein | 2 | 2010 | 12 | 0.150 |
Why?
|
| Cell Membrane | 3 | 2014 | 676 | 0.150 |
Why?
|
| Cell Line | 5 | 2019 | 2483 | 0.150 |
Why?
|
| Factor Xa | 1 | 2019 | 3 | 0.150 |
Why?
|
| Receptors, Lipoprotein | 1 | 1999 | 4 | 0.150 |
Why?
|
| Congo Red | 3 | 2011 | 5 | 0.150 |
Why?
|
| Intracellular Space | 1 | 2019 | 38 | 0.150 |
Why?
|
| Muramidase | 3 | 2016 | 32 | 0.150 |
Why?
|
| Chromatography, Affinity | 1 | 2019 | 73 | 0.150 |
Why?
|
| Biocatalysis | 1 | 2019 | 55 | 0.140 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2021 | 340 | 0.140 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2019 | 41 | 0.140 |
Why?
|
| Aspartic Acid | 2 | 2009 | 62 | 0.140 |
Why?
|
| Models, Chemical | 4 | 2009 | 186 | 0.140 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 327 | 0.140 |
Why?
|
| Receptors, Immunologic | 1 | 1999 | 143 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2019 | 557 | 0.140 |
Why?
|
| Brain Chemistry | 2 | 2016 | 110 | 0.140 |
Why?
|
| Glutamic Acid | 3 | 2009 | 136 | 0.130 |
Why?
|
| Colitis | 1 | 2020 | 264 | 0.130 |
Why?
|
| Lymphocyte Activation | 3 | 2016 | 822 | 0.130 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 1997 | 22 | 0.130 |
Why?
|
| Dictyostelium | 1 | 1997 | 43 | 0.130 |
Why?
|
| Vacuoles | 1 | 1997 | 49 | 0.130 |
Why?
|
| Lysine | 4 | 2009 | 170 | 0.130 |
Why?
|
| Thiocyanates | 2 | 1988 | 11 | 0.120 |
Why?
|
| Surface-Active Agents | 1 | 2016 | 58 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 588 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2020 | 608 | 0.110 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 154 | 0.110 |
Why?
|
| Amino Acid Substitution | 3 | 2007 | 335 | 0.110 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2014 | 4 | 0.110 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2014 | 12 | 0.110 |
Why?
|
| Molecular Weight | 7 | 1997 | 280 | 0.110 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2014 | 16 | 0.110 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 66 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 94 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 845 | 0.100 |
Why?
|
| Membrane Proteins | 3 | 2000 | 1290 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 291 | 0.100 |
Why?
|
| Membrane Glycoproteins | 4 | 2019 | 446 | 0.100 |
Why?
|
| Neoplasms | 3 | 2019 | 3349 | 0.100 |
Why?
|
| HLA-A2 Antigen | 1 | 2013 | 32 | 0.100 |
Why?
|
| HLA-D Antigens | 1 | 2013 | 20 | 0.100 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 130 | 0.100 |
Why?
|
| Escherichia coli | 4 | 2014 | 572 | 0.100 |
Why?
|
| Micelles | 4 | 2014 | 57 | 0.100 |
Why?
|
| Oncogene Proteins, Viral | 2 | 2004 | 34 | 0.090 |
Why?
|
| Molecular Chaperones | 2 | 2006 | 125 | 0.090 |
Why?
|
| Protein Biosynthesis | 2 | 2014 | 393 | 0.090 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2012 | 4 | 0.090 |
Why?
|
| Oligopeptides | 3 | 2013 | 205 | 0.090 |
Why?
|
| Lactoylglutathione Lyase | 1 | 2012 | 6 | 0.090 |
Why?
|
| Serum Albumin, Bovine | 3 | 1991 | 46 | 0.090 |
Why?
|
| Pyruvaldehyde | 1 | 2012 | 10 | 0.090 |
Why?
|
| Particle Size | 3 | 2016 | 130 | 0.090 |
Why?
|
| Fibrinopeptide B | 1 | 1991 | 1 | 0.090 |
Why?
|
| Arteriosclerosis | 1 | 1991 | 107 | 0.090 |
Why?
|
| Diffusion | 2 | 2009 | 95 | 0.090 |
Why?
|
| Receptors, Drug | 1 | 1991 | 51 | 0.080 |
Why?
|
| Fluorescent Dyes | 3 | 2005 | 257 | 0.080 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2011 | 54 | 0.080 |
Why?
|
| Hypercholesterolemia | 1 | 1991 | 161 | 0.080 |
Why?
|
| Surface Plasmon Resonance | 1 | 2010 | 49 | 0.080 |
Why?
|
| Protein Engineering | 2 | 2002 | 159 | 0.080 |
Why?
|
| Huntington Disease | 1 | 2010 | 36 | 0.080 |
Why?
|
| Models, Immunological | 1 | 2010 | 86 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2002 | 435 | 0.080 |
Why?
|
| HLA Antigens | 1 | 2012 | 238 | 0.080 |
Why?
|
| In Vitro Techniques | 3 | 2005 | 945 | 0.080 |
Why?
|
| Lipoproteins, HDL | 2 | 2001 | 92 | 0.080 |
Why?
|
| Antigens, Bacterial | 1 | 2010 | 135 | 0.080 |
Why?
|
| Chaperonins | 1 | 2010 | 10 | 0.080 |
Why?
|
| Chitin | 1 | 2010 | 10 | 0.080 |
Why?
|
| Surface Properties | 5 | 2014 | 130 | 0.080 |
Why?
|
| Benzophenones | 1 | 2010 | 16 | 0.080 |
Why?
|
| Base Sequence | 6 | 2006 | 2224 | 0.080 |
Why?
|
| Transition Temperature | 1 | 2009 | 9 | 0.080 |
Why?
|
| Guinea Pigs | 1 | 1990 | 161 | 0.080 |
Why?
|
| Tight Junctions | 2 | 2022 | 158 | 0.080 |
Why?
|
| Leucine | 1 | 2009 | 57 | 0.070 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 335 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2010 | 554 | 0.070 |
Why?
|
| Anxiety | 1 | 2012 | 370 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 10 | 2014 | 3616 | 0.070 |
Why?
|
| Glutamine | 1 | 2009 | 100 | 0.070 |
Why?
|
| Albumins | 2 | 1988 | 126 | 0.070 |
Why?
|
| Acylation | 2 | 2004 | 66 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2010 | 214 | 0.070 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2009 | 53 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2010 | 355 | 0.070 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2001 | 321 | 0.070 |
Why?
|
| Binding, Competitive | 3 | 1996 | 136 | 0.070 |
Why?
|
| Embryo, Mammalian | 2 | 1999 | 220 | 0.070 |
Why?
|
| Lipoproteins, HDL2 | 1 | 2008 | 5 | 0.070 |
Why?
|
| Lipoproteins, HDL3 | 1 | 2008 | 8 | 0.070 |
Why?
|
| Glutamates | 1 | 1988 | 85 | 0.070 |
Why?
|
| Heparin Lyase | 2 | 1999 | 4 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2022 | 1145 | 0.070 |
Why?
|
| Isoleucine | 1 | 2008 | 18 | 0.070 |
Why?
|
| Exons | 1 | 2010 | 457 | 0.070 |
Why?
|
| Bacterial Vaccines | 1 | 2008 | 44 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 2008 | 100 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 2007 | 2 | 0.070 |
Why?
|
| Fatty Acids | 1 | 1988 | 145 | 0.070 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2008 | 56 | 0.070 |
Why?
|
| Osmolar Concentration | 2 | 1997 | 166 | 0.070 |
Why?
|
| Aldehydes | 1 | 2007 | 21 | 0.070 |
Why?
|
| Rats | 7 | 2014 | 4074 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2014 | 353 | 0.060 |
Why?
|
| Dementia | 2 | 2000 | 227 | 0.060 |
Why?
|
| Algorithms | 1 | 1995 | 2003 | 0.060 |
Why?
|
| Aminocaproic Acid | 2 | 1997 | 3 | 0.060 |
Why?
|
| Insulysin | 1 | 2007 | 66 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 320 | 0.060 |
Why?
|
| Peptoids | 1 | 2006 | 1 | 0.060 |
Why?
|
| Nanotubes, Peptide | 1 | 2006 | 1 | 0.060 |
Why?
|
| Jejunum | 3 | 2019 | 78 | 0.060 |
Why?
|
| Chylomicrons | 1 | 1985 | 12 | 0.060 |
Why?
|
| Lymph | 1 | 1985 | 14 | 0.060 |
Why?
|
| alpha-Synuclein | 1 | 2005 | 28 | 0.060 |
Why?
|
| Cross-Linking Reagents | 2 | 2003 | 89 | 0.060 |
Why?
|
| Osteomalacia | 5 | 1982 | 13 | 0.060 |
Why?
|
| Fibroblasts | 2 | 1999 | 766 | 0.060 |
Why?
|
| Spectrophotometry | 1 | 2005 | 102 | 0.060 |
Why?
|
| Mice, Transgenic | 4 | 2013 | 1607 | 0.050 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 2 | 2019 | 15 | 0.050 |
Why?
|
| Heparin | 1 | 1985 | 182 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 106 | 0.050 |
Why?
|
| Crystallography, X-Ray | 3 | 2014 | 531 | 0.050 |
Why?
|
| Glycosylation | 2 | 2019 | 142 | 0.050 |
Why?
|
| Solutions | 1 | 2004 | 84 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2010 | 1006 | 0.050 |
Why?
|
| Amyloidosis | 1 | 2005 | 136 | 0.050 |
Why?
|
| Inflammation | 3 | 2020 | 1133 | 0.050 |
Why?
|
| Neoplasms, Experimental | 2 | 2002 | 263 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2005 | 186 | 0.050 |
Why?
|
| ras Proteins | 1 | 2004 | 137 | 0.050 |
Why?
|
| Diphenylhexatriene | 1 | 2003 | 2 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 23 | 0.050 |
Why?
|
| Subtilisins | 2 | 2000 | 27 | 0.050 |
Why?
|
| Cattle | 4 | 2016 | 397 | 0.050 |
Why?
|
| Esters | 1 | 2003 | 31 | 0.050 |
Why?
|
| Thermodynamics | 2 | 2001 | 327 | 0.050 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 160 | 0.050 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2022 | 16 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 4 | 1984 | 42 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1945 | 0.050 |
Why?
|
| Occludin | 1 | 2022 | 66 | 0.050 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2022 | 70 | 0.050 |
Why?
|
| COS Cells | 1 | 2002 | 163 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2014 | 374 | 0.040 |
Why?
|
| Cetrimonium Compounds | 1 | 2001 | 2 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2002 | 121 | 0.040 |
Why?
|
| Enzyme Stability | 1 | 2001 | 49 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2006 | 1419 | 0.040 |
Why?
|
| Chymotrypsin | 1 | 2001 | 29 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2001 | 8 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 270 | 0.040 |
Why?
|
| Peptide Mapping | 2 | 1999 | 24 | 0.040 |
Why?
|
| Gastrointestinal Diseases | 2 | 1980 | 156 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2014 | 403 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2001 | 173 | 0.040 |
Why?
|
| Pressure | 1 | 2001 | 174 | 0.040 |
Why?
|
| Karyopherins | 1 | 2020 | 16 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2004 | 449 | 0.040 |
Why?
|
| Liver | 3 | 1996 | 1230 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2001 | 234 | 0.040 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2000 | 6 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 2000 | 29 | 0.040 |
Why?
|
| Papilloma | 1 | 2000 | 23 | 0.040 |
Why?
|
| Carbon Isotopes | 1 | 2000 | 59 | 0.040 |
Why?
|
| Papillomaviridae | 1 | 2001 | 184 | 0.040 |
Why?
|
| Cholecalciferol | 2 | 1991 | 36 | 0.040 |
Why?
|
| Neurofibrils | 1 | 1999 | 4 | 0.040 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 1999 | 4 | 0.040 |
Why?
|
| Arginine | 1 | 2000 | 143 | 0.040 |
Why?
|
| Ribosomal Proteins | 2 | 2001 | 47 | 0.040 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1999 | 66 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1999 | 87 | 0.040 |
Why?
|
| Chlorates | 1 | 1999 | 1 | 0.040 |
Why?
|
| Scavenger Receptors, Class A | 1 | 1999 | 5 | 0.040 |
Why?
|
| Scavenger Receptors, Class B | 1 | 1999 | 4 | 0.040 |
Why?
|
| Receptors, Scavenger | 1 | 1999 | 5 | 0.040 |
Why?
|
| Egtazic Acid | 1 | 1999 | 32 | 0.040 |
Why?
|
| Lipid Bilayers | 2 | 2014 | 150 | 0.040 |
Why?
|
| Myosin Light Chains | 1 | 2019 | 25 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2019 | 174 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2001 | 96 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 529 | 0.040 |
Why?
|
| Blood | 1 | 1999 | 68 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 128 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 1998 | 427 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 1999 | 178 | 0.030 |
Why?
|
| Actomyosin | 1 | 2019 | 52 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 74 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2001 | 386 | 0.030 |
Why?
|
| Phosphatidylcholines | 3 | 2014 | 49 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 743 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1998 | 145 | 0.030 |
Why?
|
| Apolipoproteins | 3 | 1986 | 34 | 0.030 |
Why?
|
| Liver Diseases | 1 | 1980 | 250 | 0.030 |
Why?
|
| Putrescine | 1 | 1997 | 8 | 0.030 |
Why?
|
| Proton-Translocating ATPases | 1 | 1997 | 24 | 0.030 |
Why?
|
| Salts | 1 | 1997 | 18 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 1997 | 21 | 0.030 |
Why?
|
| Peptide Initiation Factors | 2 | 1987 | 30 | 0.030 |
Why?
|
| Amines | 1 | 1997 | 31 | 0.030 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1997 | 18 | 0.030 |
Why?
|
| Proline | 1 | 1997 | 51 | 0.030 |
Why?
|
| Mitochondria | 2 | 2014 | 650 | 0.030 |
Why?
|
| Growth Inhibitors | 1 | 1997 | 41 | 0.030 |
Why?
|
| Neoplasm Proteins | 2 | 1998 | 553 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1997 | 65 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1997 | 83 | 0.030 |
Why?
|
| Alanine | 1 | 1997 | 82 | 0.030 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 1997 | 9 | 0.030 |
Why?
|
| Isoxazoles | 1 | 1997 | 81 | 0.030 |
Why?
|
| Immunodominant Epitopes | 1 | 1997 | 26 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 1996 | 5 | 0.030 |
Why?
|
| Dynamic Light Scattering | 1 | 2016 | 3 | 0.030 |
Why?
|
| Dithiothreitol | 1 | 2016 | 25 | 0.030 |
Why?
|
| Ethylenediamines | 1 | 2016 | 14 | 0.030 |
Why?
|
| Tranexamic Acid | 1 | 1997 | 48 | 0.030 |
Why?
|
| RNA Helicases | 1 | 1997 | 45 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1997 | 276 | 0.030 |
Why?
|
| Ileum | 3 | 1984 | 179 | 0.030 |
Why?
|
| Caffeine | 1 | 1997 | 86 | 0.030 |
Why?
|
| Isothiocyanates | 2 | 1988 | 7 | 0.030 |
Why?
|
| Apolipoproteins A | 1 | 1996 | 10 | 0.030 |
Why?
|
| Tryptophan | 1 | 2016 | 108 | 0.030 |
Why?
|
| Antigens | 1 | 1997 | 225 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1997 | 212 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 988 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 735 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 713 | 0.030 |
Why?
|
| Cholesterol | 2 | 2001 | 376 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 161 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 418 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 1397 | 0.030 |
Why?
|
| Macrophages | 1 | 1999 | 643 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2014 | 3633 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2014 | 52 | 0.030 |
Why?
|
| Glioma | 1 | 1997 | 309 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 1987 | 325 | 0.030 |
Why?
|
| Reference Values | 1 | 1995 | 608 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2014 | 113 | 0.030 |
Why?
|
| Luciferases | 1 | 2014 | 128 | 0.030 |
Why?
|
| Scattering, Small Angle | 1 | 2014 | 37 | 0.030 |
Why?
|
| Calcifediol | 3 | 1991 | 23 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2014 | 277 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 722 | 0.030 |
Why?
|
| Th1 Cells | 1 | 1995 | 173 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 1028 | 0.030 |
Why?
|
| Vitamin D | 5 | 1984 | 286 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 2896 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 894 | 0.020 |
Why?
|
| Proteolysis | 1 | 2014 | 129 | 0.020 |
Why?
|
| DNA, Complementary | 3 | 2001 | 380 | 0.020 |
Why?
|
| Papillomavirus E7 Proteins | 2 | 2004 | 31 | 0.020 |
Why?
|
| Cross-Priming | 1 | 2013 | 59 | 0.020 |
Why?
|
| Fibrinogen | 2 | 1982 | 48 | 0.020 |
Why?
|
| Cord Factors | 2 | 1982 | 2 | 0.020 |
Why?
|
| Male | 12 | 2014 | 47263 | 0.020 |
Why?
|
| Vitamin D Deficiency | 3 | 1988 | 118 | 0.020 |
Why?
|
| Fibrinopeptide A | 1 | 1991 | 3 | 0.020 |
Why?
|
| Vitamin D-Binding Protein | 1 | 1991 | 7 | 0.020 |
Why?
|
| Glycolipids | 2 | 1982 | 27 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 684 | 0.020 |
Why?
|
| Complementarity Determining Regions | 1 | 2012 | 26 | 0.020 |
Why?
|
| Entropy | 1 | 2012 | 40 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 118 | 0.020 |
Why?
|
| Laurates | 1 | 1991 | 2 | 0.020 |
Why?
|
| Sutures | 1 | 1991 | 60 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 195 | 0.020 |
Why?
|
| Calcitriol | 2 | 1991 | 173 | 0.020 |
Why?
|
| Femoral Artery | 1 | 1991 | 96 | 0.020 |
Why?
|
| Recurrence | 2 | 2013 | 1264 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 1991 | 67 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2010 | 38 | 0.020 |
Why?
|
| Antigenic Variation | 1 | 2010 | 29 | 0.020 |
Why?
|
| Rabbits | 1 | 1991 | 582 | 0.020 |
Why?
|
| Progesterone | 1 | 1991 | 126 | 0.020 |
Why?
|
| X-Rays | 1 | 2010 | 139 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 1997 | 828 | 0.020 |
Why?
|
| Crystallization | 1 | 2010 | 219 | 0.020 |
Why?
|
| Furin | 2 | 2000 | 11 | 0.020 |
Why?
|
| Aspirin | 1 | 1991 | 168 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 582 | 0.020 |
Why?
|
| Crohn Disease | 3 | 1982 | 859 | 0.020 |
Why?
|
| United Kingdom | 2 | 2000 | 212 | 0.020 |
Why?
|
| Female | 13 | 2013 | 51761 | 0.020 |
Why?
|
| Oleic Acid | 1 | 1988 | 15 | 0.020 |
Why?
|
| Reye Syndrome | 1 | 1988 | 16 | 0.020 |
Why?
|
| Oleic Acids | 1 | 1988 | 33 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 1988 | 13 | 0.020 |
Why?
|
| Borrelia | 1 | 2008 | 3 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1988 | 145 | 0.020 |
Why?
|
| Methods | 1 | 2008 | 134 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2000 | 317 | 0.020 |
Why?
|
| Cells | 1 | 1987 | 30 | 0.020 |
Why?
|
| H-2 Antigens | 2 | 1998 | 58 | 0.020 |
Why?
|
| DNA, Neoplasm | 2 | 2001 | 267 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 1987 | 44 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 2 | 2000 | 87 | 0.020 |
Why?
|
| Ultraviolet Rays | 2 | 2001 | 198 | 0.020 |
Why?
|
| Transfection | 2 | 2000 | 883 | 0.020 |
Why?
|
| Acetylgalactosamine | 1 | 2006 | 7 | 0.020 |
Why?
|
| Lepidoptera | 1 | 1986 | 16 | 0.020 |
Why?
|
| Computational Biology | 1 | 2010 | 618 | 0.020 |
Why?
|
| Galactosyltransferases | 1 | 2006 | 37 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2006 | 38 | 0.020 |
Why?
|
| Lipoprotein Lipase | 1 | 1986 | 14 | 0.020 |
Why?
|
| Immunization | 2 | 1998 | 154 | 0.020 |
Why?
|
| Milk | 1 | 1986 | 56 | 0.020 |
Why?
|
| Moths | 1 | 1986 | 33 | 0.010 |
Why?
|
| Species Specificity | 1 | 2008 | 690 | 0.010 |
Why?
|
| Models, Biological | 1 | 2013 | 1805 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 1334 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2023 | 0.010 |
Why?
|
| beta 2-Glycoprotein I | 1 | 1985 | 5 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1985 | 23 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1997 | 1842 | 0.010 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2005 | 29 | 0.010 |
Why?
|
| Epitopes | 1 | 2006 | 259 | 0.010 |
Why?
|
| Obesity | 2 | 1984 | 1077 | 0.010 |
Why?
|
| 2,4-Dinitrophenol | 1 | 1984 | 3 | 0.010 |
Why?
|
| Dinitrophenols | 1 | 1984 | 7 | 0.010 |
Why?
|
| Calcium | 3 | 1984 | 1203 | 0.010 |
Why?
|
| Solvents | 1 | 1984 | 91 | 0.010 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 1984 | 13 | 0.010 |
Why?
|
| Liver Cirrhosis, Biliary | 2 | 1984 | 28 | 0.010 |
Why?
|
| DNA | 1 | 1990 | 1275 | 0.010 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1984 | 24 | 0.010 |
Why?
|
| Lipids | 1 | 1985 | 295 | 0.010 |
Why?
|
| Polystyrenes | 3 | 1991 | 7 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2000 | 2858 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 2002 | 13 | 0.010 |
Why?
|
| Pancreatic Diseases | 2 | 1980 | 61 | 0.010 |
Why?
|
| Tumor Escape | 1 | 2002 | 56 | 0.010 |
Why?
|
| Chemistry | 1 | 1982 | 46 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1982 | 65 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 218 | 0.010 |
Why?
|
| Insulin | 1 | 2007 | 1224 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2002 | 153 | 0.010 |
Why?
|
| Carbon | 1 | 2002 | 99 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 238 | 0.010 |
Why?
|
| Tritium | 1 | 2001 | 113 | 0.010 |
Why?
|
| Clonal Deletion | 1 | 2001 | 24 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 87 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 1982 | 177 | 0.010 |
Why?
|
| Viral Vaccines | 1 | 2001 | 38 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2001 | 141 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2001 | 99 | 0.010 |
Why?
|
| DNA Primers | 1 | 2001 | 530 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 1980 | 16 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2001 | 287 | 0.010 |
Why?
|
| Ribs | 1 | 1980 | 49 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2001 | 369 | 0.010 |
Why?
|
| Hydroxycholecalciferols | 1 | 1980 | 14 | 0.010 |
Why?
|
| Collagen | 1 | 1982 | 313 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 779 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 813 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 2000 | 20 | 0.010 |
Why?
|
| Bile Ducts | 1 | 1980 | 62 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2001 | 2070 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 9770 | 0.010 |
Why?
|
| Plasmids | 1 | 1999 | 275 | 0.010 |
Why?
|
| Cricetinae | 1 | 1999 | 533 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1999 | 119 | 0.010 |
Why?
|
| Cancer Vaccines | 1 | 2000 | 168 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 1980 | 252 | 0.010 |
Why?
|
| Bone Diseases | 1 | 1978 | 51 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1998 | 304 | 0.010 |
Why?
|
| Alleles | 1 | 2001 | 1163 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2001 | 506 | 0.010 |
Why?
|
| Vaccination | 1 | 2000 | 326 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1947 | 0.010 |
Why?
|
| Adult | 7 | 2000 | 29587 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 1997 | 27 | 0.010 |
Why?
|
| Mammals | 1 | 2000 | 268 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1997 | 94 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1997 | 116 | 0.010 |
Why?
|
| Aged | 2 | 2013 | 21844 | 0.010 |
Why?
|
| DEAD-box RNA Helicases | 1 | 1997 | 80 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1999 | 670 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1997 | 375 | 0.010 |
Why?
|
| Time Factors | 2 | 2001 | 5577 | 0.010 |
Why?
|
| Lasers | 1 | 1976 | 105 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1997 | 830 | 0.010 |
Why?
|
| Hybridomas | 1 | 1995 | 61 | 0.010 |
Why?
|
| Cell Survival | 1 | 1997 | 1017 | 0.010 |
Why?
|
| Codon | 1 | 1995 | 116 | 0.010 |
Why?
|
| Clone Cells | 1 | 1995 | 223 | 0.010 |
Why?
|
| Histidine | 1 | 1995 | 69 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1995 | 370 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 2 | 1987 | 480 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1995 | 246 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1999 | 901 | 0.010 |
Why?
|
| Drosophila melanogaster | 2 | 1987 | 654 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1997 | 701 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1995 | 1110 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 1980 | 2688 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1997 | 843 | 0.010 |
Why?
|
| Computer Simulation | 1 | 1994 | 1147 | 0.000 |
Why?
|
| Bone and Bones | 2 | 1982 | 272 | 0.000 |
Why?
|
| Biopsy | 2 | 1984 | 1225 | 0.000 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 1988 | 7 | 0.000 |
Why?
|
| Child | 1 | 1980 | 7750 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1987 | 12 | 0.000 |
Why?
|
| Spores, Fungal | 1 | 1987 | 18 | 0.000 |
Why?
|
| Fluorometry | 1 | 1987 | 30 | 0.000 |
Why?
|
| Spermidine | 1 | 1987 | 13 | 0.000 |
Why?
|
| Hemolymph | 1 | 1986 | 2 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1987 | 228 | 0.000 |
Why?
|
| Cyanogen Bromide | 1 | 1986 | 7 | 0.000 |
Why?
|
| Isoflurophate | 1 | 1986 | 3 | 0.000 |
Why?
|
| Endopeptidases | 1 | 1986 | 114 | 0.000 |
Why?
|
| Melitten | 1 | 1985 | 9 | 0.000 |
Why?
|
| Vinyl Compounds | 1 | 1985 | 8 | 0.000 |
Why?
|
| Adsorption | 1 | 1985 | 52 | 0.000 |
Why?
|
| Polylysine | 1 | 1985 | 32 | 0.000 |
Why?
|
| Phospholipids | 1 | 1985 | 109 | 0.000 |
Why?
|
| Absorption | 1 | 1984 | 26 | 0.000 |
Why?
|
| Intestinal Absorption | 1 | 1984 | 125 | 0.000 |
Why?
|
| Magnesium | 1 | 1984 | 175 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1984 | 233 | 0.000 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 1982 | 5 | 0.000 |
Why?
|
| Ergocalciferols | 1 | 1982 | 38 | 0.000 |
Why?
|
| Middle Aged | 4 | 1984 | 29532 | 0.000 |
Why?
|
| Microspheres | 1 | 1982 | 97 | 0.000 |
Why?
|
| Granuloma | 1 | 1982 | 65 | 0.000 |
Why?
|
| Blood Coagulation | 1 | 1982 | 90 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1982 | 118 | 0.000 |
Why?
|
| Mycolic Acids | 1 | 1981 | 1 | 0.000 |
Why?
|
| Smegma | 1 | 1981 | 1 | 0.000 |
Why?
|
| Mycobacterium | 1 | 1981 | 19 | 0.000 |
Why?
|
| Molecular Conformation | 1 | 1981 | 112 | 0.000 |
Why?
|
| Oxytetracycline | 1 | 1980 | 2 | 0.000 |
Why?
|
| Tetracycline | 1 | 1980 | 13 | 0.000 |
Why?
|
| Malabsorption Syndromes | 1 | 1980 | 21 | 0.000 |
Why?
|
| Acute Disease | 1 | 1982 | 860 | 0.000 |
Why?
|
| Microcirculation | 1 | 1980 | 101 | 0.000 |
Why?
|
| Lung Diseases | 1 | 1982 | 284 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1980 | 194 | 0.000 |
Why?
|
| Dogs | 1 | 1980 | 642 | 0.000 |
Why?
|
| Postgastrectomy Syndromes | 1 | 1978 | 1 | 0.000 |
Why?
|
| Cholestasis | 1 | 1978 | 48 | 0.000 |
Why?
|
| Intestinal Diseases | 1 | 1978 | 87 | 0.000 |
Why?
|
| Graft Survival | 1 | 1980 | 994 | 0.000 |
Why?
|
| Acridines | 1 | 1976 | 4 | 0.000 |
Why?
|
| Chlorophyta | 1 | 1976 | 12 | 0.000 |
Why?
|
| Cell Nucleolus | 1 | 1976 | 25 | 0.000 |
Why?
|
| Mitochondria, Muscle | 1 | 1976 | 24 | 0.000 |
Why?
|
| Liver Cirrhosis | 1 | 1978 | 290 | 0.000 |
Why?
|
| Chromosomes | 1 | 1976 | 91 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1984 | 4818 | 0.000 |
Why?
|
| Cell Division | 1 | 1976 | 690 | 0.000 |
Why?
|
| Pregnancy | 1 | 1981 | 3269 | 0.000 |
Why?
|
| Myocardium | 1 | 1976 | 578 | 0.000 |
Why?
|